Tapewire

Nasdaq · USD

FENC

FENNEC PHARMACEUTICALS INC.

Export transactions ↓
Tapewire entity
5601
SEC CIK
0001211583
Parsed reports
281

Last 12 months

Inside the activity.

0 purchase rows · 19 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202504
Dec 202502
Jan 202601
Feb 202601
Mar 202601
Apr 202601
May 202602
Jun 202601
Jul 202601
Aug 202603
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 31, 2026 Filed Jun 1, 2026 20:05 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantCommon shares 1,703 $0.00 $0.00
Disclosure

SEC source: 0001468308-26-000022 · form4-06012026_040601.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 289,269

F1 · security: Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025.

Read SEC document
May 31, 2026 Filed Jun 1, 2026 20:05 UTC
Hackman Jeffrey S.Director · Chief Executive Officer
GrantCommon Shares 1,159 $0.00 $0.00
Disclosure

SEC source: 0001926254-26-000008 · form4-06012026_040603.xml · nonDerivative · entry 1

Hackman Jeffrey S. · CIK 0001926254 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,825

F1 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
May 31, 2026 Filed Jun 2, 2026 20:05 UTC
Raykov RostyDirector
GrantCommon shares 2,778 $0.00 $0.00
Disclosure

SEC source: 0001468316-26-000015 · form4-06022026_040601.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,229

F1 · security: Represents shares released from restriction from shares awarded 5/16/2024.

Read SEC document
May 11, 2026 Filed May 12, 2026 20:05 UTC Exercise / conversionStock Option · Derivative 14,344 $2.44 Strike: $2.44 $34,999.36
Disclosure

SEC source: 0001185945-26-000002 · form4-05122026_040501.xml · derivative · entry 3

RALLIS CHRIS A · CIK 0001185945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 186,189

Underlying: Common shares · 14,344 shares

Expires 2026-06-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Represents options exercised pursuant to a 10b5-1 plan adopted on May 19, 2025.

Read SEC document
May 11, 2026 Filed May 12, 2026 20:05 UTC SaleCommon Shares 8,346 $7.04 $58,755.84
Disclosure

SEC source: 0001185945-26-000002 · form4-05122026_040501.xml · nonDerivative · entry 2

RALLIS CHRIS A · CIK 0001185945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 63,077

F2 · security: Shares sold to satisfy tax obligation on option exercise.

Read SEC document
May 11, 2026 Filed May 12, 2026 20:05 UTC Exercise / conversionCommon Shares 14,344 $2.44 $34,999.36
Disclosure

SEC source: 0001185945-26-000002 · form4-05122026_040501.xml · nonDerivative · entry 1

RALLIS CHRIS A · CIK 0001185945 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,423

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on May 19, 2025.

Read SEC document
May 01, 2026 Filed May 1, 2026 21:00 UTC
Raykov RostyDirector
Exercise / conversionStock Options · Derivative 15,598 $2.45 Strike: $2.45 $38,215.10
Disclosure

SEC source: 0001468316-26-000013 · form4-05012026_090522.xml · derivative · entry 4

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,571,792

Underlying: options · 15,598 shares

Expires 2026-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025.

Read SEC document
May 01, 2026 Filed May 1, 2026 21:00 UTC
Raykov RostyDirector
SaleCommon shares 10,781 $6.47 $69,753.07
Disclosure

SEC source: 0001468316-26-000013 · form4-05012026_090522.xml · nonDerivative · entry 3

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 121,451

F3 · security: Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025.

Read SEC document
May 01, 2026 Filed May 1, 2026 21:00 UTC
Raykov RostyDirector
Exercise / conversionCommon shares 15,598 $2.45 $38,215.10
Disclosure

SEC source: 0001468316-26-000013 · form4-05012026_090522.xml · nonDerivative · entry 2

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 132,232

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025.

Read SEC document
April 30, 2026 Filed May 1, 2026 20:05 UTC
Sayad Pierre SargisChief Medical Officer
Exercise / conversionCommon Shares 168 $0.00 $0.00
Disclosure

SEC source: 0002043395-26-000004 · form4-05012026_040509.xml · nonDerivative · entry 1

Sayad Pierre Sargis · CIK 0002043395 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,847

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
April 30, 2026 Filed May 1, 2026 20:05 UTC
Evans Terry LChief Commercial Officer
Exercise / conversionCommon Shares 168 $0.00 $0.00
Disclosure

SEC source: 0002043317-26-000004 · form4-05012026_040507.xml · nonDerivative · entry 1

Evans Terry L · CIK 0002043317 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,847

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
April 30, 2026 Filed May 1, 2026 20:05 UTC
Cioffi Christiana MarieChief Strategy Officer
Exercise / conversionCommon shares 155 $0.00 $0.00
Disclosure

SEC source: 0002043411-26-000006 · form4-05012026_040505.xml · nonDerivative · entry 1

Cioffi Christiana Marie · CIK 0002043411 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,020

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
April 30, 2026 Filed May 1, 2026 20:05 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
Exercise / conversionCommon shares 1,703 $0.00 $0.00
Disclosure

SEC source: 0001468308-26-000020 · form4-05012026_040501.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 287,566

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares released from restriction from shares awarded 5/16/2024 and 3/28/2025.

Read SEC document
April 30, 2026 Filed May 1, 2026 21:00 UTC
Raykov RostyDirector
Exercise / conversionCommon shares 2,778 $0.00 $0.00
Disclosure

SEC source: 0001468316-26-000013 · form4-05012026_090522.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,634

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares released from restriction from shares awarded 5/16/2024.

Read SEC document
April 30, 2026 Filed May 1, 2026 20:05 UTC
Hackman Jeffrey S.Director · Chief Executive Officer
Exercise / conversionCommon Shares 1,159 $0.00 $0.00
Disclosure

SEC source: 0001926254-26-000006 · form4-05012026_040503.xml · nonDerivative · entry 1

Hackman Jeffrey S. · CIK 0001926254 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 61,666

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:05 UTC
Raykov RostyDirector
Exercise / conversionStock Options · Derivative 15,598 $2.45 Strike: $2.45 $38,215.10
Disclosure

SEC source: 0001468316-26-000010 · form4-04022026_040403.xml · derivative · entry 4

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,587,390

Underlying: options · 15,598 shares

Expires 2026-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025.

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:05 UTC
Raykov RostyDirector
SaleCommon shares 10,946 $6.31 $69,069.26
Disclosure

SEC source: 0001468316-26-000010 · form4-04022026_040403.xml · nonDerivative · entry 3

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 113,856

F3 · security: Shares sold to satisfy tax obligation on option exercise pursuant to a 10b5-1 plan adopted on September 19, 2025..

Read SEC document
April 01, 2026 Filed Apr 2, 2026 20:05 UTC
Raykov RostyDirector
Exercise / conversionCommon shares 15,598 $2.45 $38,215.10
Disclosure

SEC source: 0001468316-26-000010 · form4-04022026_040403.xml · nonDerivative · entry 2

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 124,802

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Sayad Pierre SargisChief Medical Officer
GrantStock Options · Derivative 120,000 $5.77 Strike: $5.77 $692,400.00
Disclosure

SEC source: 0002043395-26-000002 · form4-04022026_040411.xml · derivative · entry 4

Sayad Pierre Sargis · CIK 0002043395 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,000

Underlying: Common Shares · 120,000 shares

Expires 2036-03-31

F3 · security: On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

F4 · derivative.exercise_date: One-third of the shares subject to this option may be exercised as of March 31, 2027 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Sayad Pierre SargisChief Medical Officer
Exercise / conversionCommon shares 171 $0.00 $0.00
Disclosure

SEC source: 0002043395-26-000002 · form4-04022026_040411.xml · nonDerivative · entry 2

Sayad Pierre Sargis · CIK 0002043395 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,627

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Sayad Pierre SargisChief Medical Officer
Exercise / conversionCommon Shares 18,456 $0.00 $0.00
Disclosure

SEC source: 0002043395-26-000002 · form4-04022026_040411.xml · nonDerivative · entry 1

Sayad Pierre Sargis · CIK 0002043395 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,456

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents settlement of PSUs that vested on March 31, 2026.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Evans Terry LChief Commercial Officer
GrantStock Options · Derivative 120,000 $5.77 Strike: $5.77 $692,400.00
Disclosure

SEC source: 0002043317-26-000002 · form4-04022026_040409.xml · derivative · entry 4

Evans Terry L · CIK 0002043317 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 270,000

Underlying: Common Shares · 120,000 shares

Expires 2036-03-31

F3 · security: On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

F4 · derivative.exercise_date: One-third of the shares subject to this option may be exercised as of March 31, 2027 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Evans Terry LChief Commercial Officer
Exercise / conversionCommon shares 171 $0.00 $0.00
Disclosure

SEC source: 0002043317-26-000002 · form4-04022026_040409.xml · nonDerivative · entry 2

Evans Terry L · CIK 0002043317 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,627

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Evans Terry LChief Commercial Officer
Exercise / conversionCommon Shares 18,456 $0.00 $0.00
Disclosure

SEC source: 0002043317-26-000002 · form4-04022026_040409.xml · nonDerivative · entry 1

Evans Terry L · CIK 0002043317 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,456

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents settlement of PSUs that vested on March 31, 2026.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Cioffi Christiana MarieChief Strategy Officer
GrantStock Options · Derivative 120,000 $5.77 Strike: $5.77 $692,400.00
Disclosure

SEC source: 0002043411-26-000004 · form4-04022026_040407.xml · derivative · entry 4

Cioffi Christiana Marie · CIK 0002043411 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 265,300

Underlying: Common Shares · 120,000 shares

Expires 2036-03-31

F3 · security: On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

F4 · derivative.exercise_date: One-third of the shares subject to this option may be exercised as of March 31, 2027 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Cioffi Christiana MarieChief Strategy Officer
Exercise / conversionCommon shares 158 $0.00 $0.00
Disclosure

SEC source: 0002043411-26-000004 · form4-04022026_040407.xml · nonDerivative · entry 2

Cioffi Christiana Marie · CIK 0002043411 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Cioffi Christiana MarieChief Strategy Officer
Exercise / conversionCommon shares 17,106 $0.00 $0.00
Disclosure

SEC source: 0002043411-26-000004 · form4-04022026_040407.xml · nonDerivative · entry 1

Cioffi Christiana Marie · CIK 0002043411 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,806

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents settlement of PSUs that vested on March 31, 2026.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Raykov RostyDirector
GrantCommon shares 5,208 $0.00 $0.00
Disclosure

SEC source: 0001468316-26-000010 · form4-04022026_040403.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,204

F1 · security: Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantStock Options · Derivative 120,000 $5.77 Strike: $5.77 $692,400.00
Disclosure

SEC source: 0001468308-26-000018 · form4-04022026_040401.xml · derivative · entry 4

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 921,045

Underlying: Options · 120,000 shares

Expires 2036-03-31

F4 · security: On March 31, 2026, granted incentive stock options to purchase 120,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

F5 · derivative.exercise_date: One-third of the shares subject to this option may be exercised as of March 31, 2027 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
Exercise / conversionCommon shares 2,213 $0.00 $0.00
Disclosure

SEC source: 0001468308-26-000018 · form4-04022026_040401.xml · nonDerivative · entry 2

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 273,593

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
Exercise / conversionCommon shares 14,724 $0.00 $0.00
Disclosure

SEC source: 0001468308-26-000018 · form4-04022026_040401.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 271,380

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents settlement of PSUs that vested on March 31, 2026.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Hackman Jeffrey S.Director · Chief Executive Officer
GrantStock Options · Derivative 200,000 $5.77 Strike: $5.77 $1,154,000.00
Disclosure

SEC source: 0001926254-26-000004 · form4-04022026_040412.xml · derivative · entry 4

Hackman Jeffrey S. · CIK 0001926254 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 725,000

Underlying: Common Shares · 200,000 shares

Expires 2036-03-31

F3 · security: On March 31, 2026, granted incentive stock options to purchase 200,000 shares of the issuers common shares pursuant to the Issuer's 2020 Equity Incentive Plan.

F4 · derivative.exercise_date: One-third of the shares subject to this option may be exercised as of March 31, 2027 ("Vesting Commencement Date"). One twenty-fourth of the shares subject to this option shall vest and may be exercised as of the last day of each month following the Vesting Commencement Date. As of March 31, 2029, 100% of the total number of shares subject to this option shall be vested.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Hackman Jeffrey S.Director · Chief Executive Officer
Exercise / conversionCommon Shares 1,159 $0.00 $0.00
Disclosure

SEC source: 0001926254-26-000004 · form4-04022026_040412.xml · nonDerivative · entry 2

Hackman Jeffrey S. · CIK 0001926254 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,564

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 20:05 UTC
Hackman Jeffrey S.Director · Chief Executive Officer
Exercise / conversionCommon Shares 16,695 $0.00 $0.00
Disclosure

SEC source: 0001926254-26-000004 · form4-04022026_040412.xml · nonDerivative · entry 1

Hackman Jeffrey S. · CIK 0001926254 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,405

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents settlement of PSUs that vested on March 31, 2026.

Read SEC document
March 28, 2026 Filed Apr 2, 2026 20:05 UTC
Sayad Pierre SargisChief Medical Officer
Exercise / conversionCommon shares 2,052 $0.00 $0.00
Disclosure

SEC source: 0002043395-26-000002 · form4-04022026_040411.xml · nonDerivative · entry 3

Sayad Pierre Sargis · CIK 0002043395 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
March 28, 2026 Filed Apr 2, 2026 20:05 UTC
Evans Terry LChief Commercial Officer
Exercise / conversionCommon shares 2,052 $0.00 $0.00
Disclosure

SEC source: 0002043317-26-000002 · form4-04022026_040409.xml · nonDerivative · entry 3

Evans Terry L · CIK 0002043317 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,679

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
March 28, 2026 Filed Apr 2, 2026 20:05 UTC
Cioffi Christiana MarieChief Strategy Officer
Exercise / conversionCommon shares 1,901 $0.00 $0.00
Disclosure

SEC source: 0002043411-26-000004 · form4-04022026_040407.xml · nonDerivative · entry 3

Cioffi Christiana Marie · CIK 0002043411 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,865

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
March 28, 2026 Filed Apr 2, 2026 20:05 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
Exercise / conversionCommon shares 12,270 $0.00 $0.00
Disclosure

SEC source: 0001468308-26-000018 · form4-04022026_040401.xml · nonDerivative · entry 3

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285,863

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
March 28, 2026 Filed Apr 2, 2026 20:05 UTC
Hackman Jeffrey S.Director · Chief Executive Officer
Exercise / conversionCommon Shares 13,943 $0.00 $0.00
Disclosure

SEC source: 0001926254-26-000004 · form4-04022026_040412.xml · nonDerivative · entry 3

Hackman Jeffrey S. · CIK 0001926254 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,507

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Represents shares released from restriction from shares awarded 3/28/2025.

Read SEC document
March 26, 2026 Filed Mar 26, 2026 20:29 UTC
Cioffi Christiana MarieChief Strategy Officer
Exercise / conversionStock Options · Derivative 4,700 $4.23 Strike: $4.23 $19,881.00
Disclosure

SEC source: 0002043411-26-000002 · form4-03262026_080303.xml · derivative · entry 2

Cioffi Christiana Marie · CIK 0002043411 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,300

Underlying: Common Shares · 4,700 shares

Expires 2034-11-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Shares acquired through the exercise of an option contract with strike price of $4.23 and an expiration date of November 13, 2034.

Read SEC document
March 26, 2026 Filed Mar 26, 2026 20:29 UTC
Cioffi Christiana MarieChief Strategy Officer
Exercise / conversionCommon shares 4,700 $4.23 $19,881.00
Disclosure

SEC source: 0002043411-26-000002 · form4-03262026_080303.xml · nonDerivative · entry 1

Cioffi Christiana Marie · CIK 0002043411 · Chief Strategy Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Shares acquired through the exercise of an option contract with strike price of $4.23 and an expiration date of November 13, 2034.

Read SEC document
March 26, 2026 Filed Mar 26, 2026 20:30 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
Exercise / conversionStock Options · Derivative 13,072 $5.10 Strike: $5.10 $66,667.20
Disclosure

SEC source: 0001468308-26-000016 · form4-03262026_080309.xml · derivative · entry 2

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 801,045

Underlying: Options · 13,072 shares

Expires 2027-06-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027.

Read SEC document
March 26, 2026 Filed Mar 26, 2026 20:30 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
Exercise / conversionCommon shares 13,072 $5.10 $66,667.20
Disclosure

SEC source: 0001468308-26-000016 · form4-03262026_080309.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 256,656

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Shares acquired through the exercise of an option contract with strike price of $5.10 and an expiration date of June 27, 2027.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:05 UTC
Raykov RostyDirector
Exercise / conversionStock Options · Derivative 15,598 $2.45 Strike: $2.45 $38,215.10
Disclosure

SEC source: 0001468316-26-000008 · form4-03032026_040301.xml · derivative · entry 4

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,587,390

Underlying: options · 15,598 shares

Expires 2026-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Represents options exercised pursuant to a 10b5-1 plan adopted on September 19, 2025.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:05 UTC
Raykov RostyDirector
SaleCommon shares 10,079 $8.36 $84,260.44
Disclosure

SEC source: 0001468316-26-000008 · form4-03032026_040301.xml · nonDerivative · entry 2

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 103,996

F2 · security: Shares sold to satisfy tax obligation on option exercise.

Read SEC document
March 02, 2026 Filed Mar 3, 2026 21:05 UTC
Raykov RostyDirector
Exercise / conversionCommon shares 15,598 $2.45 $38,215.10
Disclosure

SEC source: 0001468316-26-000008 · form4-03032026_040301.xml · nonDerivative · entry 1

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 114,075

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on September 19, 2025.

Read SEC document
February 28, 2026 Filed Mar 3, 2026 21:05 UTC
Raykov RostyDirector
GrantCommon shares 5,208 $0.00 $0.00
Disclosure

SEC source: 0001468316-26-000008 · form4-03032026_040301.xml · nonDerivative · entry 3

Raykov Rosty · CIK 0001468316 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 109,204

F3 · security: Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024.

Read SEC document
February 28, 2026 Filed Mar 3, 2026 21:05 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
GrantCommon shares 1,191 $0.00 $0.00
Disclosure

SEC source: 0001468308-26-000014 · form4-03032026_040303.xml · nonDerivative · entry 1

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 243,584

F1 · security: Represents shares released from restriction from shares awarded 3/31/2023 and 5/16/2024.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 23:43 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
Exercise / conversionStock Options · Derivative 2,450 $4.08 Strike: $4.08 $9,996.00
Disclosure

SEC source: 0001468308-26-000012 · form4-02192026_110240.xml · derivative · entry 3

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 814,117

Underlying: Options · 2,450 shares

Expires 2031-12-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Shares acquired through the exercise of an option contract with strike price of $4.08 and an expiration date of December 20, 2031.

Read SEC document
February 18, 2026 Filed Feb 19, 2026 23:43 UTC
Andrade RobertCHIEF FINANCIAL OFFICER
Exercise / conversionCommon shares 27,285 $0.00 $0.00
Disclosure

SEC source: 0001468308-26-000012 · form4-02192026_110240.xml · nonDerivative · entry 2

Andrade Robert · CIK 0001468308 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,393

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Represents settlement of PSUs that vested on February 18, 2026.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.